Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 3.880
-0.060 (-1.52%)
Oct 26, 2026, 1:06 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €108.64 million as of October 26, 2026. It is the 23,707th most valuable company in the world and the 80th biggest in Belgium. Its market cap has decreased by 28.15% in one year.
Market Cap
108.64M
Enterprise Value
101.37M
Revenue
9.83M
Global Rank
Country Rank
#80 Belgium
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 108.64M, a decrease of -55.60%. That is a compound annual growth rate of -12.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 108.64M | -43.27% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 51.99B |
| argenx SE | 48.92B |
| Financière de Tubize | 9.82B |
| Onward Medical | 143.92M |
| European Medical Solutions | 15.49M |
| Celyad Oncology | 10.03M |
| BioSenic | 1.31M |
| Oxurion NV | 112.59K |